Arvee Laboratories India Q3 Results 2025 on 15 Feb, 2025: profit falls by 37.5% YOY, profit at ₹0.15 crore and revenue at ₹8.91 crore
Arvee Laboratories India Q3 Results 2025 on 15 Feb, 2025: Revenue increased by 15.71% YoY & profit decreased by 37.5% YoY, profit at ₹0.15 crore and revenue at ₹8.91 crore
Arvee Laboratories India Q3 Results 2025:Arvee Laboratories India declared their Q3 results on 12 Feb, 2025, reporting a revenue increase of 15.71% year-on-year but a concerning profit decline of 37.5%. The profit stood at ₹0.15 crore, while revenue reached ₹8.91 crore.
However, when compared to the previous quarter, the company faced significant challenges, with revenue declining by 28.89% and profit plummeting by 84.69%. This troubling trend raises questions about the sustainability of their current financial strategies.
Additionally, the Selling, General & Administrative expenses have risen, increasing by 4.46% quarter-on-quarter and by 19.39% year-on-year. This rise in expenses could further impact profitability if not managed effectively.
The operating income also showed a stark decrease, down by 94.17% quarter-on-quarter and 58.82% year-on-year, indicating a substantial contraction in operational performance.
Earnings per share (EPS) for Q3 is reported at ₹0.14, which represents a decrease of 36.36% year-on-year. This decline in EPS signals a potential decrease in investor confidence moving forward.
Arvee Laboratories India has delivered a return of -2.5% in the last week, -23.37% in the last six months, and a -16.4% return year-to-date, showcasing a troubling trend for investors.
Currently, Arvee Laboratories India holds a market capitalization of ₹153.29 crore, with a 52-week high of ₹315 and a low of ₹117.05. This volatility reflects the challenges the company faces in the competitive market.
Arvee Laboratories India Financials
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 8.91 | 12.53 | -28.89% | 7.7 | +15.71% |
| Selling/ General/ Admin Expenses Total | 1.17 | 1.12 | +4.46% | 0.98 | +19.39% |
| Depreciation/ Amortization | 0.28 | 0.3 | -6.67% | 0.35 | -20% |
| Total Operating Expense | 8.84 | 11.32 | -21.91% | 7.53 | +17.4% |
| Operating Income | 0.07 | 1.2 | -94.17% | 0.17 | -58.82% |
| Net Income Before Taxes | 0.21 | 1.31 | -83.97% | 0.32 | -34.38% |
| Net Income | 0.15 | 0.98 | -84.69% | 0.24 | -37.5% |
| Diluted Normalized EPS | 0.14 | 0.89 | -84.27% | 0.22 | -36.36% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
- Top Gainers
- Top Losers
- 52 Week High